Literature DB >> 16152689

Italian multicentric pilot study on MBL2 genetic polymorphisms in HIV positive pregnant women and their children.

Sergio Crovella1, Maria Bernardon, Laura Braida, Michele Boniotto, Secondo Guaschino, Enrico Ferrazzi, Pasquale Martinelli, Salvatore Alberico.   

Abstract

OBJECTIVE: We investigated genetic polymorphisms of MBL2 gene, in a cohort of 90 Italian HIV-1 pregnant seropositive women and their children in order to understand whether the MBL2 genotype of HIV-1 positive mothers might be related to their ability to transmit the virus to their children.
MATERIALS AND METHODS: DNA was extracted from Iso Code Stix cards, and MBL2 genotyping was performed by Melting Temperature Assay.
RESULTS: The frequency of the MBL2 0/0 homozygotes was higher in HIV-1 positive mothers than in healthy controls, the MBL2 0/0 genotype was more frequent in children born from HIV positive mothers than healthy subjects.
CONCLUSIONS: We have confirmed the association of polymorphisms involving a gene of the innate immunity with an increased risk of being infected by HIV. These polymorphisms were also evidenced in children born from HIV+ mothers, but the risk of infection was strongly reduced by cesarean delivery and by antiretroviral treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16152689     DOI: 10.1080/14767050500072599

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

2.  MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia.

Authors:  Luisa Zupin; Vania Polesello; Ludovica Segat; Louise Kuhn; Sergio Crovella
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.